Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)
A Registry Study of Cerebral Venous Sinus Thrombosis in China
1 other identifier
observational
3,276
1 country
1
Brief Summary
This study will investigate the epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of cerebral venous thrombosis in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2022
CompletedFirst Posted
Study publicly available on registry
July 7, 2022
CompletedStudy Start
First participant enrolled
August 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2023
CompletedFebruary 26, 2024
February 1, 2024
1.3 years
July 2, 2022
February 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Favorable clinical outcome (modified Rankin score 0-1)
Baseline to three years
All-cause mortality
A combination of death form of all causes
Baseline to three years
Secondary Outcomes (9)
Recurrence of cerebral venous thrombosis
Baseline to three years
Favorable clinical outcome (modified Rankin score 0-2)
Baseline to three years
Headache after CVT
Baseline to three years
Incidence of hemorrhagic complication
Baseline to three years
Recanalization rate of cerebral venous system
Baseline to three years
- +4 more secondary outcomes
Eligibility Criteria
Patients with cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis.
You may qualify if:
- Cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis diagnosed by digital subtraction angiography (DSA), magnetic resonance venography (MRV), computed tomography venography (CTV) or high-resolution magnetic resonance imaging (HR-MRI).
You may not qualify if:
- None of the patient, trustee or immediate family members signed the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Capital Medical Universitylead
- Brain Hospital of Hunan Provincialcollaborator
- The First Affiliated Hospital of Zhengzhou Universitycollaborator
- The Affiliated Hospital of Xuzhou Medical Universitycollaborator
- Guizhou Provincial People's Hospitalcollaborator
Study Sites (1)
Xuan Wu Hospital，Capital Medical University
Beijing, Beijing Municipality, 100069, China
Related Publications (1)
Bian H, Wang X, Liu L, Yan F, Lu S, Hui W, Zhou C, Duan J, Li M, Chen J, Meng R, Cao L, Wang L, Ji X. Multicenter registry study of cerebral venous thrombosis in china (RETAIN-CH): Rationale and design. Brain Behav. 2024 Apr;14(4):e3353. doi: 10.1002/brb3.3353.
PMID: 38622893DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Capital Medical University
Study Record Dates
First Submitted
July 2, 2022
First Posted
July 7, 2022
Study Start
August 20, 2022
Primary Completion
December 20, 2023
Study Completion
December 20, 2023
Last Updated
February 26, 2024
Record last verified: 2024-02